Pathogenetic Classification (Types A and B)
In modern clinical practice, four main types of reactions are distinguished based on their dose relationship, time of onset, and predictability.
Type A (Augmented — exaggerated, predictable) These are the most common reactions, directly dependent on the dose and pharmacological activity of the drug. Essentially, they stem from the primary or secondary pharmacodynamic effect of the medication.
- Example: Ulcerogenic action (severe gastric mucosal ulceration) when taking acetylsalicylic acid.
Type B (Bizarre — aberrant, unpredictable) These reactions are dose-independent and entirely unrelated to the direct pharmacological action of the drug. They are always based on an individual patient's heightened sensitivity.
- Forms of manifestation: Drug intolerance, genetically determined idiosyncrasy, and allergic reactions.
Chronic and Delayed Reactions (Types C and D)
Type C (Chronic) Long-term drug administration is the primary condition for these states. Key manifestations include:
- Tolerance (a marked decrease in therapeutic effect).
- Withdrawal syndrome (sharp clinical deterioration after stopping pharmacotherapy).
- Drug dependence and accumulation (buildup of the substance or its effect in the body).
- Suppression of endogenous hormone production (typical of hormone therapy).
Type D (Delayed) Delayed effects appearing long after cessation of therapy (sometimes years later or even in the next generation). These include carcinogenicity (tumor development), mutagenicity (genomic and chromosomal mutations), as well as embryotoxicity and teratogenicity. Diagnosis is extremely difficult due to the large time gap hindering causal links.
Classification by Clinical Severity
Criteria for grading reaction severity are based on the need to discontinue the drug, administer additional treatment, and the impact on hospitalization duration.
- Mild: Drug discontinuation is not required, no special treatment is needed, and symptoms resolve spontaneously.
- Moderate: Drug discontinuation and specific therapy are strictly required. The complication prolongs hospitalization.
- Severe: Life-threatening, carries a high risk of disability, and requires a significant extension of inpatient treatment.
- Lethal: Results in death.
Clinical Example Analysis: Thalidomide
To accurately determine the reaction type, one must correlate the mechanism of action with specific clinical manifestations. The historical use of thalidomide demonstrates the classic picture of a teratogenic effect. The drug, taken by pregnant women, caused massive severe congenital malformations (phocomelia) in children. Since the negative effect appeared in offspring long after exposure, the conclusion is clear: thalidomide's teratogenic effect belongs to Type D delayed reactions.